Loading…
Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin
This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV...
Saved in:
Published in: | PLoS ONE 2016, Vol.11 (12), p.e0168468 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Report |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 12 |
container_start_page | e0168468 |
container_title | PLoS ONE |
container_volume | 11 |
creator | Álvarez-Marín, Rocío López-Rojas, Rafael Márquez, Juan Antonio Gómez, María José Molina, José Cisneros, José Miguel Ortiz-Leyba, Carlos Aznar, Javier Garnacho-Montero, José Pachón, Jerónimo |
description | This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation [greater than or equal to]6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC.sub.90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii. |
doi_str_mv | 10.1371/journal.pone.0168468 |
format | report |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_incontextgauss_IOV_A474490072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A474490072</galeid><sourcerecordid>A474490072</sourcerecordid><originalsourceid>FETCH-gale_incontextgauss_IOV_A4744900723</originalsourceid><addsrcrecordid>eNqVjs1Kw1AQhS-iYP15AxezdZF408S0XZZaaUFQbOm2TNJpOiWdW3LnUvuAvpepKLh1dQ6Hj49jzF1i4yTtJQ9bFxrBOt47odgmeT_L-2emkwzSbpR3bXr-p1-aK--31j6m_TzvmM-Rq9krCzw5jxXBgXXjgsKLwxVLdZoJph7G6zWXWLILHg4bEpg3hHoiRtgUuCehXfROvpWhKAxLFlJXYKnUQIFhhyLMsCBRrlFdEw29dyWj0grehMLOCWMrC74diiPMtEEW_30IJlxtYBZ8SXvlgmvWI6iD3_M35mKNtafbn7w298_j-WgSVVjTkqV0ovShVSv3y-nrYjnMelk2sLbXTf_DfgEDBHjC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Álvarez-Marín, Rocío ; López-Rojas, Rafael ; Márquez, Juan Antonio ; Gómez, María José ; Molina, José ; Cisneros, José Miguel ; Ortiz-Leyba, Carlos ; Aznar, Javier ; Garnacho-Montero, José ; Pachón, Jerónimo</creator><creatorcontrib>Álvarez-Marín, Rocío ; López-Rojas, Rafael ; Márquez, Juan Antonio ; Gómez, María José ; Molina, José ; Cisneros, José Miguel ; Ortiz-Leyba, Carlos ; Aznar, Javier ; Garnacho-Montero, José ; Pachón, Jerónimo</creatorcontrib><description>This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation [greater than or equal to]6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC.sub.90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0168468</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Acinetobacter infections ; Care and treatment ; Colistin ; Dose-response relationship ; Health aspects ; Ventilator-associated pneumonia</subject><ispartof>PLoS ONE, 2016, Vol.11 (12), p.e0168468</ispartof><tpages>e0168468</tpages><format>e0168468</format><rights>COPYRIGHT 2016 Public Library of Science</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,4476,27902</link.rule.ids></links><search><creatorcontrib>Álvarez-Marín, Rocío</creatorcontrib><creatorcontrib>López-Rojas, Rafael</creatorcontrib><creatorcontrib>Márquez, Juan Antonio</creatorcontrib><creatorcontrib>Gómez, María José</creatorcontrib><creatorcontrib>Molina, José</creatorcontrib><creatorcontrib>Cisneros, José Miguel</creatorcontrib><creatorcontrib>Ortiz-Leyba, Carlos</creatorcontrib><creatorcontrib>Aznar, Javier</creatorcontrib><creatorcontrib>Garnacho-Montero, José</creatorcontrib><creatorcontrib>Pachón, Jerónimo</creatorcontrib><title>Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin</title><title>PLoS ONE</title><description>This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation [greater than or equal to]6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC.sub.90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii.</description><subject>Acinetobacter infections</subject><subject>Care and treatment</subject><subject>Colistin</subject><subject>Dose-response relationship</subject><subject>Health aspects</subject><subject>Ventilator-associated pneumonia</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2016</creationdate><recordtype>report</recordtype><recordid>eNqVjs1Kw1AQhS-iYP15AxezdZF408S0XZZaaUFQbOm2TNJpOiWdW3LnUvuAvpepKLh1dQ6Hj49jzF1i4yTtJQ9bFxrBOt47odgmeT_L-2emkwzSbpR3bXr-p1-aK--31j6m_TzvmM-Rq9krCzw5jxXBgXXjgsKLwxVLdZoJph7G6zWXWLILHg4bEpg3hHoiRtgUuCehXfROvpWhKAxLFlJXYKnUQIFhhyLMsCBRrlFdEw29dyWj0grehMLOCWMrC74diiPMtEEW_30IJlxtYBZ8SXvlgmvWI6iD3_M35mKNtafbn7w298_j-WgSVVjTkqV0ovShVSv3y-nrYjnMelk2sLbXTf_DfgEDBHjC</recordid><startdate>20161219</startdate><enddate>20161219</enddate><creator>Álvarez-Marín, Rocío</creator><creator>López-Rojas, Rafael</creator><creator>Márquez, Juan Antonio</creator><creator>Gómez, María José</creator><creator>Molina, José</creator><creator>Cisneros, José Miguel</creator><creator>Ortiz-Leyba, Carlos</creator><creator>Aznar, Javier</creator><creator>Garnacho-Montero, José</creator><creator>Pachón, Jerónimo</creator><general>Public Library of Science</general><scope>IOV</scope></search><sort><creationdate>20161219</creationdate><title>Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin</title><author>Álvarez-Marín, Rocío ; López-Rojas, Rafael ; Márquez, Juan Antonio ; Gómez, María José ; Molina, José ; Cisneros, José Miguel ; Ortiz-Leyba, Carlos ; Aznar, Javier ; Garnacho-Montero, José ; Pachón, Jerónimo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_incontextgauss_IOV_A4744900723</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acinetobacter infections</topic><topic>Care and treatment</topic><topic>Colistin</topic><topic>Dose-response relationship</topic><topic>Health aspects</topic><topic>Ventilator-associated pneumonia</topic><toplevel>online_resources</toplevel><creatorcontrib>Álvarez-Marín, Rocío</creatorcontrib><creatorcontrib>López-Rojas, Rafael</creatorcontrib><creatorcontrib>Márquez, Juan Antonio</creatorcontrib><creatorcontrib>Gómez, María José</creatorcontrib><creatorcontrib>Molina, José</creatorcontrib><creatorcontrib>Cisneros, José Miguel</creatorcontrib><creatorcontrib>Ortiz-Leyba, Carlos</creatorcontrib><creatorcontrib>Aznar, Javier</creatorcontrib><creatorcontrib>Garnacho-Montero, José</creatorcontrib><creatorcontrib>Pachón, Jerónimo</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Álvarez-Marín, Rocío</au><au>López-Rojas, Rafael</au><au>Márquez, Juan Antonio</au><au>Gómez, María José</au><au>Molina, José</au><au>Cisneros, José Miguel</au><au>Ortiz-Leyba, Carlos</au><au>Aznar, Javier</au><au>Garnacho-Montero, José</au><au>Pachón, Jerónimo</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin</atitle><jtitle>PLoS ONE</jtitle><date>2016-12-19</date><risdate>2016</risdate><volume>11</volume><issue>12</issue><spage>e0168468</spage><pages>e0168468-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation [greater than or equal to]6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC.sub.90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii.</abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0168468</doi><tpages>e0168468</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PLoS ONE, 2016, Vol.11 (12), p.e0168468 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_gale_incontextgauss_IOV_A474490072 |
source | Publicly Available Content Database; PubMed Central |
subjects | Acinetobacter infections Care and treatment Colistin Dose-response relationship Health aspects Ventilator-associated pneumonia |
title | Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T23%3A38%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Colistin%20Dosage%20without%20Loading%20Dose%20Is%20Efficacious%20when%20Treating%20Carbapenem-Resistant%20Acinetobacter%20baumannii%20Ventilator-Associated%20Pneumonia%20Caused%20by%20Strains%20with%20High%20Susceptibility%20to%20Colistin&rft.jtitle=PLoS%20ONE&rft.au=%C3%81lvarez-Mar%C3%ADn,%20Roc%C3%ADo&rft.date=2016-12-19&rft.volume=11&rft.issue=12&rft.spage=e0168468&rft.pages=e0168468-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0168468&rft_dat=%3Cgale%3EA474490072%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-gale_incontextgauss_IOV_A4744900723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A474490072&rfr_iscdi=true |